返回
Hua Medicine（02552.HK）价格
02552.HK 股价走势图
HUA MEDICINE-B (02552.HK)
Hua Medicine
HK$3.12
-0.63%
$-0.02
休市： Feb 13, 16:00:00 HKT
关键数据
前收盘价
$3.14
开盘价
$3.14
当日区间
$3.02 - $3.15
52周范围
$1.24 - $4.95
交易量
--
平均成交量
3.5M
每股收益（TTM）
1.21
股息收益率
--
市值
$2.9B
什么是 HUA MEDICINE-B？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
